281 related articles for article (PubMed ID: 21992443)
61. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
[TBL] [Abstract][Full Text] [Related]
62. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
63. Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database.
Moreira DM; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2010 Jan; 105(1):28-33. PubMed ID: 19522861
[TBL] [Abstract][Full Text] [Related]
64. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
Rogers E; Ohori M; Kassabian VS; Wheeler TM; Scardino PT
J Urol; 1995 Jan; 153(1):104-10. PubMed ID: 7526002
[TBL] [Abstract][Full Text] [Related]
65. Salvage options for biochemical recurrence after primary therapy for prostate cancer.
Bong GW; Keane TE
Can J Urol; 2007 Dec; 14 Suppl 1():2-9. PubMed ID: 18163938
[TBL] [Abstract][Full Text] [Related]
66. Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy.
Neuhof D; Hentschel T; Bischof M; Sroka-Perez G; Hohenfellner M; Debus J
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1411-7. PubMed ID: 17275204
[TBL] [Abstract][Full Text] [Related]
67. Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry.
Dhar N; Ward JF; Cher ML; Jones JS
BJU Int; 2011 Aug; 108(4):508-12. PubMed ID: 21722288
[TBL] [Abstract][Full Text] [Related]
68. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
Vaidya A; Soloway MS
J Urol; 2000 Dec; 164(6):1998-2001. PubMed ID: 11061900
[TBL] [Abstract][Full Text] [Related]
69. Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level.
McGuire BB; Helfand BT; Loeb S; Hu Q; O'Brien D; Cooper P; Yang X; Catalona WJ
BJU Int; 2012 Jun; 109(12):1764-9. PubMed ID: 22017732
[TBL] [Abstract][Full Text] [Related]
70. An algorithm for managing the failure of external beam radiotherapy in prostate cancer.
Dudderidge T; Payne H; Emberton M
BJU Int; 2007 Sep; 100(3):518-27. PubMed ID: 17573894
[TBL] [Abstract][Full Text] [Related]
71. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography.
Gelet A; Chapelon JY; Poissonnier L; Bouvier R; Rouvière O; Curiel L; Janier M; Vallancien G
Urology; 2004 Apr; 63(4):625-9. PubMed ID: 15072864
[TBL] [Abstract][Full Text] [Related]
72. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
[TBL] [Abstract][Full Text] [Related]
73. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option.
Allen GW; Howard AR; Jarrard DF; Ritter MA
Cancer; 2007 Oct; 110(7):1405-16. PubMed ID: 17685384
[TBL] [Abstract][Full Text] [Related]
74. Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.
Gomez-Veiga F; Mariño A; Alvarez L; Rodriguez I; Fernandez C; Pertega S; Candal A
BJU Int; 2012 Feb; 109 Suppl 1():17-21. PubMed ID: 22239225
[TBL] [Abstract][Full Text] [Related]
75. Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy.
Robinson JW; Donnelly BJ; Coupland K; Siever JE; Saliken JC; Scott C; Brasher PM; Ernst DS
Urol Oncol; 2006; 24(6):472-86. PubMed ID: 17138127
[TBL] [Abstract][Full Text] [Related]
76. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736
[TBL] [Abstract][Full Text] [Related]
77. Salvage cryoablation for local recurrence of prostatic cancer after curative therapy.
Barat M; Colleter L; Mongiat-Artus P; Jolibois Z; Quero L; Hennequin C; Desgrandchamps F; de Kerviler E
Diagn Interv Imaging; 2019 Nov; 100(11):679-687. PubMed ID: 31331832
[TBL] [Abstract][Full Text] [Related]
78. Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy.
Stephenson AJ; Scardino PT; Bianco FJ; Eastham JA
Curr Treat Options Oncol; 2004 Oct; 5(5):357-65. PubMed ID: 15341674
[TBL] [Abstract][Full Text] [Related]
79. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy: A Combined Analysis of Two Centers.
Chin JL; Lavi A; Metcalfe MJ; Siddiqui K; Dewar M; Petros FG; Li R; Nogueras González GM; Wang X; Nair SM; Ward JF; Pisters L
J Urol; 2021 Sep; 206(3):646-654. PubMed ID: 33908799
[TBL] [Abstract][Full Text] [Related]
80. Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer.
Nair SM; Peters M; Kurver P; Lavi A; Verhoeff JJC; van der Voort van Zyp JRN; van Son MJ; Chin JL
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):186-192. PubMed ID: 32814843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]